These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1428880)

  • 1. [Graft versus host disease].
    Volc-Platzer B
    Hautarzt; 1992 Oct; 43(10):669-77. PubMed ID: 1428880
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-versus-host disease.
    Nijhawan A; Drolet BA
    Adv Dermatol; 2001; 17():115-39. PubMed ID: 11758114
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.
    Ferrara JL; Abhyankar S; Gilliland DG
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1216-7. PubMed ID: 8442093
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of cytokines in graft-versus-host reactions and disease.
    Jadus MR; Wepsic HT
    Bone Marrow Transplant; 1992 Jul; 10(1):1-14. PubMed ID: 1515873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and functions of inflammatory cells isolated from acute graft-versus-host disease target organs after bone marrow transplantation in the rat.
    Renkonen R; Leszczynski D; Wangel A; Häyry P
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2689. PubMed ID: 3274579
    [No Abstract]   [Full Text] [Related]  

  • 6. Helper T-lymphocyte precursor frequencies predict risks of graft-versus-host disease in bone marrow transplantation.
    Batchelor JR; Schwarer AP; Yin ZJ; Barrett AJ; Goldman JM; Lechler RI
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1237-8. PubMed ID: 8442100
    [No Abstract]   [Full Text] [Related]  

  • 7. T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma.
    Przepiorka D; Giralt S; Huh YO; Andreeff M; Luna M; Reading C; Thomas M; Champlin RE
    Transplant Proc; 1992 Dec; 24(6):2906-7. PubMed ID: 1465994
    [No Abstract]   [Full Text] [Related]  

  • 8. Allorecognition and graft-versus-host disease.
    Theobald M
    Bone Marrow Transplant; 1995 Apr; 15(4):489-98. PubMed ID: 7655371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes virus immunity and acute graft-versus-host disease.
    Gratama JW; Weiland HT; Hekker AC; Weijers TF; The TH; Stijnen T; Zwaan FE; Vossen JM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2680-2. PubMed ID: 2856285
    [No Abstract]   [Full Text] [Related]  

  • 10. Effector cells of graft-versus-host disease, host resistance, and the graft-versus-leukemia effect: summary of a workshop on bone marrow transplantation.
    Ringdén O; Deeg HJ; Beschorner W; Slavin S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2758-61. PubMed ID: 3547953
    [No Abstract]   [Full Text] [Related]  

  • 11. Engraftment of allogeneic bone marrow cells: experimental investigations on the role of cell dose, graft-versus-host reactive T cells and pretransplant immunosuppression.
    Uharek L; Glass B; Gassmann W; Eckstein V; Steinmann J; Loeffler H; Mueller-Ruchholtz W
    Transplant Proc; 1992 Dec; 24(6):3023-5. PubMed ID: 1466042
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum.
    Oluwole SF; Engelstad K; Hardy MA
    Transplant Proc; 1992 Dec; 24(6):2858-9. PubMed ID: 1465974
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytokines in veno-occlusive disease of the liver after bone marrow transplantation.
    Remberger M; Ringdén O
    Transplant Proc; 1995 Dec; 27(6):3533-4. PubMed ID: 8540087
    [No Abstract]   [Full Text] [Related]  

  • 14. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation.
    Champlin R
    Hematol Oncol Clin North Am; 1990 Jun; 4(3):687-98. PubMed ID: 2193019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human graft-versus-host disease.
    Parkman R
    Immunodefic Rev; 1991; 2(4):253-64. PubMed ID: 2059433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociating graft-vs-host disease from the graft-vs-leukemia effect of allogeneic T cells: the potential role of IL-2.
    Sykes M
    Bone Marrow Transplant; 1992; 10 Suppl 1():1-4. PubMed ID: 1521080
    [No Abstract]   [Full Text] [Related]  

  • 18. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-versus-leukemia activity after T-cell depletion using counterflow centrifugation.
    de Witte T; Preijers F; Schattenberg A
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():103-5. PubMed ID: 2202463
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunopathogenesis of GVHD.
    Imamura M; Tanaka J; Hashino S; Kobayashi S; Imai K; Asaka M; Kasai M
    Transplant Proc; 1996 Jun; 28(3):1181-3. PubMed ID: 8658619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.